
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence.
The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.
Drug developers are increasingly adopting AI for discovery and safety testing to get faster and cheaper results, in line with the U.S. Food and Drug Administration's push to reduce animal testing in the near future.
Drug development software maker Certara and biotechs such as Schrodinger and Recursion Pharmaceuticals are using the booming technology to predict how experimental drugs might be absorbed, distributed or trigger toxic side-effects.
"We believe the Cell Atlas is a key development that will enable us to significantly scale AI for drug discovery," said Illumina CEO Jacob Thaysen.
The Atlas will capture how 1 billion individual cells respond to genetic changes via CRISPR across more than 200 disease-relevant cell lines.
These cell lines have been selected for their relevance to diseases, many of which have been historically difficult to decode, including immune disorders and cancer as well as cardiometabolic, neurological and rare genetic diseases.
The Atlas will enable users to characterize drug and disease mechanisms of action, explore potential new indications and validate candidate targets from human genetics.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
LATEST POSTS
- 1
Spain's Easter processions draw more tourists amid Iran war - 2
Sydney Sweeney is returning in 'The Housemaid's Secret': What to know about 'The Housemaid' sequel - 3
Instructions to Keep up with Your Traded Teeth for Life span - 4
Vote In favor of Your Favored Occasion Arranging Administration - 5
An Ideal Getaway - Spots for Solo Travel
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
A hospital discharged a woman in labor. This lawmaker wants change.
Mount Everest Climbers 'Poisoned' by Guides Prompting Mass Helicopter Rescues in $20 Million Insurance Fraud Scheme, Police Say
These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
From Dread to Certainty: Individual Accounts of Strengthening
Disney's latest short film 'Versa' tackles a difficult subject: Pregnancy loss. It's resonating with viewers.
Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet.
How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
Council removes proposal to rename park named after former president of Israel













